Beckman Coulter Life Sciences Launches RNA Extraction Kit Validated for use in Virus Research Workflows
Researchers Worldwide to Benefit from New RNA Extraction Kit with Strong Supply Chain
(Indianapolis, Indiana – May 12, 2020) Beckman Coulter Life Sciences today announced the launch of RNAdvance Viral XP, a new RNA extraction kit validated for use in infectious disease and real-time PCR virus research. The kit is now available for purchase as high-throughput laboratories worldwide ramp up RNA extraction capabilities.
RNAdvance Viral XP is intended for use in high-throughput research workflows to extract viral RNA from swab samples, an essential step in the overall workflow. After RNA extraction, the collected RNA is used in qRT-PCR kits to test whether the RNA from a virus is present, yielding a positive or negative result.
“The isolation of RNA from viral samples is a critical step in researching viruses and other deadly pathogens,” said Greg Milosevich, President, Beckman Coulter Life Sciences. “Our development team has worked closely with global research partners during the past several months to provide customers with a high-performing, validated viral extraction solution during this time of increased need.”
Beckman Coulter Life Sciences worked with iRepertoire in Huntsville, Alabama to develop the reagent kit’s method. iRepertoire then independently validated the method. Both parties were pleased with the results.
“We performed more than 100 RNA extractions and more than 500 qPCR reactions during a three-day period to validate RNAdvance Viral XP,” said Miranda L. Byrne-Steele, Ph.D., Director of Operations and R&D, iRepertoire. “The results clearly demonstrate this new solution from Beckman Coulter Life Sciences is a viable alternative to help alleviate a critical shortage in the RNA extraction kit supply chain.”
“Doing our part to support customers during a time of increased need is a priority for me and all Beckman Coulter Life Sciences associates as we build a robust supply chain, scale production and increase field support capabilities,” added Milosevich. “We’re all in this together, and I’m confident our technology will expand the availability of extraction solutions for research laboratories around the world.”
Beckman Coulter Life Sciences is an operating company within Danaher Corporation’s (NYSE: DHR) Life Sciences platform. For more information about RNAdvance Viral XP, visit beckman.com/reagents/genomic/rna-isolation/viral. Follow @Beckman Coulter Life Sciences on LinkedIn for real-time updates and insights across the business.
About Beckman Coulter Life Sciences
Life sciences. Research. Precision manufacturing. If your life’s calling is in any of these or related fields, you need to know Beckman Coulter Life Sciences. Since 1935, the Beckman name has been synonymous with technologies that simplify and automate complex biomedical testing. Decades later, our global organization also came to embody the scientific legacy of the Coulter name. Today, Beckman Coulter Life Sciences is a trusted, worldwide resource for tools to help optimize research and manufacturing efficiency. Centrifuges. Particle counters/analyzers. Automated liquid handlers. Flow cytometers. All these products—and many more—continue to make a difference in people’s lives by improving the productivity of dedicated scientists, quality control experts and others. From prestigious universities and major pharmaceutical companies, to small biotech startups, food/beverage and electronics manufacturing facilities, you can find our name virtually everywhere. For more details, explore beckman.com.
Beckman Coulter genomic reagents and kits are not intended or validated for use in the diagnosis of disease or other conditions.